PARK AVENUE SECURITIES LLC

Broker-Dealer

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1071640 NEW YORK, NY

Position in UTHR

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$562,419

+$67,874 QoQ

Shares Held

1,038

+24.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#550

of 870 holders

Holding Since

Dec 2022

12 quarters on record

Healthcare · as of Jun 30, 2026

PARK AVENUE SECURITIES LLC holds $5,937,881 across 8 Drug Manufacturers - Specialty & Generic names. UTHR ranks #6 (9.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	8,601	$1,449,612
2	HLN	Haleon plc	111,923	$1,044,241
3	KNSA	Kiniksa Pharmaceuticals International, plc	14,734	$942,239
4	TAK	Takeda Pharmaceutical Co Ltd	44,827	$718,576
5	TEVA	Teva Pharmaceutical Industries Ltd	19,191	$650,191
6	UTHR	UNITED THERAPEUTICS Corp This page	1,038	$562,419
7	ZTS	Zoetis Inc.	4,994	$358,868
8	AMRX	Amneal Pharmaceuticals, Inc.	12,232	$211,735

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$562,419	1,038	+24.5%	Shares	Sole	2026-07-20
2026-03-31	$494,545	834	-15.2%	Shares	Sole	2026-04-07
2025-09-30	$412,502	984	-58.2%	Shares	Sole	2025-10-23
2025-06-30	$676,134	2,353	+1.7%	Shares	Sole	2025-07-14
2025-03-31	$713,336	2,314	-11.5%	Shares	Sole	2025-04-14
2024-12-31	$922,323	2,614	+18.4%	Shares	Sole	2025-01-14
2024-09-30	$790,878	2,207	+8.3%	Shares	Sole	2024-10-03
2024-06-30	$648,886	2,037	+30.4%	Shares	Sole	2024-07-09
2024-03-31	$358,822	1,562	+11.0%	Shares	Sole	2024-04-10
2023-12-31	$309,385	1,407	+4.9%	Shares	Sole	2024-01-10
2023-09-30	$302,891	1,341	+20.2%	Shares	Sole	2023-10-26
2022-12-31	$310,348	1,116	—	Shares	Sole	2023-01-24
No filing history on record for this holder in this stock.